Even as Covid vaccine demand rises, firms may take some weeks to up production
Indications are that India’s vaccine production is expected to be limited for a few more weeks though a step-up is expected as Serum Institute of India and Bharat Biotech ramp up capacity, some of which is expected to be ready by next month, prompting the government to prioritise vaccinating segments that are seen to be more vulnerable.
You Might Like
💡 newsR Knowledge: Other News Mentions
At Rs 700-Rs 1,500, price of Covid vaccine in India’s private sector among costliestFrom Rs 250, the cost of vaccines in the private sector has shot up by up to six times. It now ranges from Rs 700-900 for Covishield manufactured by the Serum..
Covid update: 23 Delhi patients 'missing'; black fungus alert in Gujarat
Credit: HT Digital Content Duration: 03:11Published
Celebs Pour on the Love for Mom For Mother's Day 2021It's Mother's Day again -- and if you thought Hollywood would skip a beat due to COVID, you're wrong ... because they laid it on thick for mama bear, just like..
Is it time to 'unlearn' some Covid-era norms?
Credit: Bleacher Report AOL Duration: 05:28Published
Israel sending special team of experts to help India amid COVID second wave
Credit: ANI Duration: 02:10Published
Chhattisgarh will receive 3.50 lakh doses of Covishield today
Credit: ANI Duration: 01:25Published
Serum, Bharat Biotech got advance of Rs 2,500 crore for 16 crore doses, says governmentThe government on Monday said it had paid an advance of over Rs 2,500 crore to Serum Institute of India and Bharat Biotech for supply of 16 crore doses of Covid..
Media reports alleging Centre hasn't placed any fresh order for Covid-19 vaccines incorrect: Health ministry"The news reports suggest that the last order placed with the two vaccine makers (100 million doses with SII and 20 million doses with Bharat Biotech) was in..
UK agreed to expand partnership on vaccines: MEA
Credit: ANI Duration: 01:13Published
Ahead of India-UK summit, Boris Johnson announces 1 billion pound trade dealThe UK-India trade deals include an investment of 240 million pounds by the Pune-based Serum Institute of India (SII).
Related videos from verified sources
Related news from verified sources